Fundraising Fox株式会社ONODERA GT Pharma
川崎市, JP · 1 known investors
Find your way into 株式会社ONODERA GT Pharma
Sign up to see every warm intro you have to 株式会社ONODERA GT Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社ONODERA GT Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Onodera develops AAV vector platforms for gene therapy research targeting neurological conditions. The company owns proprietary AAV vector patents, enabling internal development of therapeutic vectors without licensing costs from third parties.
Founders & leadership
佐陽
佐久間 陽介Representative Director / President Executive Officer
浅克
浅井 克仁Director / Chairman Executive Officer
村慎
村松 慎一Physician
Investors · 1
Frequently asked questions
- What does 株式会社ONODERA GT Pharma do?
- Onodera develops AAV vector platforms for gene therapy research targeting neurological conditions. The company owns proprietary AAV vector patents, enabling internal development of therapeutic vectors without licensing costs from third parties.
- Who are 株式会社ONODERA GT Pharma's investors?
- 株式会社ONODERA GT Pharma's investors include Medical Incubator Japan K.K..
- Where is 株式会社ONODERA GT Pharma headquartered?
- 株式会社ONODERA GT Pharma is headquartered in 川崎市, JP.